Brandon M. Johnson

Acetalated Dextran Microparticles for Codelivery of STING and TLR7/8 Agonists.

J. Ting, K. Ainslie, A. Macintyre, 2018, Molecular pharmaceutics.

STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN–Dependent and –Independent Immune-Regulatory Pathways

J. Ting, K. Ainslie, W. Chou, 2021, The Journal of Immunology.

STING-induced regulatory B cells compromise NK function in cancer immunity

J. Wrobel, B. Vincent, M. Gale, 2022, Nature.

Towards programming immune tolerance through geometric manipulation of phosphatidylserine.

Patrick J. Short, J. Ting, J. DeSimone, 2015, Biomaterials.

Platelet-activating factor (PAF) mediates NLRP3-NEK7 inflammasome induction independently of PAFR

B. Beutler, D. Golenbock, B. Koller, 2019, The Journal of experimental medicine.

A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer.

Kristy M Ainslie, Ning Cheng, Leaf Huang, 2018, JCI insight.

A robust microparticle platform for a STING‐targeted adjuvant that enhances both humoral and cellular immunity during vaccination

Ivo D. Shterev, J. Ting, K. Ainslie, 2017, Journal of controlled release : official journal of the Controlled Release Society.

The Innate Immune Sensor NLRC3 Acts as a Rheostat that Fine‐Tunes T Cell Responses in Infection and Autoimmunity

J. Ting, W. Chou, Haitao Guo, 2018, Immunity.

A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1-insensitive models of triple-negative breast cancer.

David B. Darr, J. Ting, K. Ainslie, 2018, JCI insight.